🕒 Last update: loading…21/11/2026

Stock Corteva, Inc. CTVA

Corteva, Inc. — Investlytic score 3/5 on the five criteria.

-
-
60/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 3/5 criteria met. Data as of 18/11/2026.

  • ✅ Price trend passed
  • ⚠️ Mixed growth
  • ✅ Debt passed
  • ✅ P/E passed
  • ❌ Correction failed

Price trend

Overall trend (8 years): the price has been multiplied by at least 1.5.

Price change 2019 → 2020: 30.86%

Price change 2020 → 2021: 22.03%

Price change 2021 → 2022: 24.40%

Price change 2022 → 2023: -18.48%

Price change 2023 → 2024: 18.92%

Price change 2024 → 2025: 17.66%

Price change 2025 → 2026: -12.33%

Price change 2026 (year to date): -13.27%

Financial growth

Revenue CAGR (8 years): 2.86%

Earnings CAGR (8 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 0.11

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: 2.39

P/E < 25.0 (maximum threshold).

Correction (6 months)

Current correction: 38.96% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, mechanical verdict of the method (hold, watch, sell: the same for all) and the detail of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Corteva, Inc.2.60.11+2.4 %🔒
SOL S.p.A.35.90.73+8.3 %–
MP Materials Corp.–0.44+18.8 %–
Vallourec S.A.9.70.40−1.1 %–
Arkema S.A.24.70.89+2.9 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Corteva, Inc. over the latest fiscal years.

Revenue
17.4 bn USD
fiscal year 2025
Net income
1.1 bn USD
fiscal year 2025
Net margin
6.3 %
fiscal year 2025
Average annual growth
+4.1 %
Revenue growth over 5 years
Market cap
6.3 bn USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
202014.2 bn681 m4.8 %n/a
202115.7 bn1.8 bn11.2 %+10.1 %
202217.5 bn1.1 bn6.6 %+11.5 %
202317.2 bn735 m4.3 %-1.3 %
202416.9 bn907 m5.4 %-1.8 %
202517.4 bn1.1 bn6.3 %+2.9 %

Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Corteva, Inc. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
fragile accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
0.93
risk zone (below 1.81)
Piotroski Score
5 / 9
4 to 6: average accounts
Net Debt / EBITDA
1.15 x
moderate debt
Fiscal year20212022202320242025
Cash and investments4.5 bn3.3 bn2.7 bn3.2 bn4.5 bn
Total Debt1.1 bn1.3 bn2.5 bn2.7 bn2.6 bn
Net Debt-3.3 bn-1.9 bn-155 m-403 m-1.9 bn
Equity25.4 bn25.3 bn25.0 bn23.8 bn24.1 bn
Total assets42.3 bn42.6 bn43.0 bn40.8 bn42.8 bn
Operating cash flow2.7 bn872 m1.8 bn2.1 bn3.4 bn
Investments (capex)573 m605 m595 m597 m591 m
Free cash-flow2.2 bn267 m1.2 bn1.5 bn2.8 bn
Share buybacks950 m1.0 bn756 m1.0 bn1.1 bn
Dividends paid397 m418 m439 m458 m475 m

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)6.71 x
Price / book value0.22 x
Return on Equity (ROE)3.1 %
Return on Invested Capital (ROIC)5.1 %
Net margin4.3 %
Debt / equity0.30 x
Current ratio1.56 x
Interest coverage13.88 x
Free cash-flow yield-2.8 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 20/11/2026.

+

Valuation and competitors

Corteva, Inc. compared with its sector on the same exchange and with its main competitors.

Company P/E
2.6
88.2 % below the sector
Sector median P/E
21.6
basic materials, NYSE
Sector over 10 years
24.7
10-year median, range 15.8 to 46.3

Direct competitors

CompanyMarket cap (USD)P/ENet margin
Corteva, Inc.6.3 bn2.66.3 %
Bioceres Crop Solutions Corp. BIOX13.4 mn/a-16.6 %
FMC Corporation FMC652 m2.0-64.6 %
American Vanguard Corporation AVD25.9 mn/a-9.7 %
Arcadia Biosciences, Inc. RKDA337,315n/a-48.1 %
Nutrien Ltd. NTR33.8 bn14.58.4 %
Origin Agritech Limited SEED9.3 mn/a-58.4 %
Sector median (NYSE)21.6

Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 12/11/2026. Competitors: comparable companies named by the data provider.

+

Analyst consensus and forecasts

What the financial analysts covering Corteva, Inc. publish: ratings, price targets and earnings forecasts.

Majority rating
buy
37 analysts
Average price target
36.73 USD
from n/a to n/a, 34 targets over 12 months
Gap with the share price
+289.5 %
price 9.43 USD on 13/11/2026

Breakdown of ratings

strong buy 0buy 25hold 10sell 2strong sell 0

Average target over the last 3 months: 36.73 USD (15 targets).

Track record against expectations: reported EPS above consensus 9 times over the last 12 releases.

Source: ratings and forecasts published by analysts, collected on 21/11/2026. An analyst rating or target is not a guarantee.

+

Who owns the stock

Free float, institutional investors, large funds, executives and elected officials: declared positions in Corteva, Inc.

Free float
99.9 %
share of freely traded shares
Large funds tracked
30
hold the stock as of 2026Q2
Executives (insiders)
3 / 0
3 purchases, 0 sales in 130 days
US elected officials
6
2 purchases, 4 sales in 12 months

Large funds tracked

FundSharesValue (USD)Weight in the fundChangeQuarter
State Street76.5 m6.5 bn0.1 %+111.8 %2026Q2
Vanguard Group80.5 m5.4 bn0.1 %+0.4 %2025Q4
BlackRock53.8 m4.6 bn0.1 %-1.6 %2026Q2
Capital World Investors42.9 m3.6 bn0.4 %+19.2 %2026Q2
Fidelity41.1 m3.5 bn0.1 %+17.4 %2026Q2
Geode Capital Management18.9 m1.6 bn0.1 %+0.9 %2026Q2
Harris Associates16.3 m1.4 bn1.9 %-1.9 %2026Q2
Northern Trust12.1 m1.0 bn0.1 %-3.3 %2026Q2

Latest insider transactions

DatePersonSideAmount
16/11/2026Page Gregory Rpurchase92,500 USD
13/11/2026Page Gregory Rpurchase92,900 USD
13/11/2026Kissam Luther C Ivpurchase300,312 USD

Elected officials' disclosures

DateOfficialSideAmount
14/10/2026Gilbert Cisnerossale$1,001 - $15,000
17/09/2026Gilbert Cisnerossale$1,001 - $15,000
04/09/2026Ro Khannapurchase$1,001 - $15,000
29/10/2024Thomas Hawley Tubervillesale$1,001 - $15,000
27/03/2026Alan Armstrongpurchase$1,001 - $15,000

Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 20/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE
IPO: 24/05/2019
ISIN code
US22052L1044
Workforce
22,000
full-time employees
Chief executive
Charles Victor Magro (Chem), MBA

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Corteva, Inc.

What is the Corteva, Inc. share price?

Latest recorded price: 9.43 USD on 13/11/2026, for a market cap of 6.3 bn USD.

What is the revenue of Corteva, Inc.?

17.4 bn USD for fiscal year 2025, with net income of 1.1 bn USD (net margin 6.3 %).

What do analysts say about Corteva, Inc.?

Out of 37 analysts: 25 buy or strong buy, 10 hold, 2 sell or strong sell. Average price target: 36.73 USD, i.e. +289.5 % from the share price.

What is the P/E ratio of Corteva, Inc.?

Trailing 12-month P/E of 2.6, against 21.6 for the sector median on the same exchange (10-year median: 24.7).

Is Corteva, Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US22052L1044).

How many employees does Corteva, Inc. have?

22,000 full-time employees according to the latest published profile.

Who runs Corteva, Inc.?

Charles Victor Magro (Chem), MBA is the company's chief executive.

Which large funds own Corteva, Inc.?

As of 2026Q2, among the large funds tracked: State Street, Vanguard Group, BlackRock, Capital World Investors, Fidelity.

07

Similar stocks